BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3717856)

  • 1. Experimental alteration of chinchilla middle ear mucosae by bacterial neuraminidase.
    LaMarco KL; Diven WF; Glew RH
    Ann Otol Rhinol Laryngol; 1986; 95(3 Pt 1):304-8. PubMed ID: 3717856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuraminidase activity in middle ear effusions.
    LaMarco KL; Diven WF; Glew RH; Doyle WJ; Cantekin EI
    Ann Otol Rhinol Laryngol; 1984; 93(1 Pt 1):76-84. PubMed ID: 6538394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic and biochemical study of vascular permeability of the middle ear mucosa in experimental otitis media.
    Sakagami M; Harada T; Juhn SK; Duvall AJ
    Ann Otol Rhinol Laryngol; 1990 Aug; 99(8):654-9. PubMed ID: 1696441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of neuraminidase on receptor-mediated adherence of Streptococcus pneumoniae to chinchilla tracheal epithelium.
    Tong HH; Liu X; Chen Y; James M; Demaria T
    Acta Otolaryngol; 2002 Jun; 122(4):413-9. PubMed ID: 12125999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of alteration of cell surface carbohydrates of the chinchilla tubotympanum and colonial opacity phenotype of Streptococcus pneumoniae during experimental pneumococcal otitis media with or without an antecedent influenza A virus infection.
    Tong HH; Grants I; Liu X; DeMaria TF
    Infect Immun; 2002 Aug; 70(8):4292-301. PubMed ID: 12117938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct evidence of bacterial biofilms in otitis media.
    Post JC
    Laryngoscope; 2001 Dec; 111(12):2083-94. PubMed ID: 11802002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with native or recombinant Streptococcus pneumoniae neuraminidase affords protection in the chinchilla otitis media model.
    Long JP; Tong HH; DeMaria TF
    Infect Immun; 2004 Jul; 72(7):4309-13. PubMed ID: 15213181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and properties of Streptococcus pneumoniae neuraminidase.
    Scanlon KL; Diven WF; Glew RH
    Enzyme; 1989; 41(3):143-50. PubMed ID: 2542012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arachidonic acid metabolites in otitis media pathogenesis.
    Jung TT
    Ann Otol Rhinol Laryngol Suppl; 1988; 132():14-8. PubMed ID: 3132884
    [No Abstract]   [Full Text] [Related]  

  • 10. A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells.
    Libby P; Alroy J; Pereira ME
    J Clin Invest; 1986 Jan; 77(1):127-35. PubMed ID: 3080470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model.
    Tong HH; Blue LE; James MA; DeMaria TF
    Infect Immun; 2000 Feb; 68(2):921-4. PubMed ID: 10639464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intranasal inoculation of Streptococcus pneumoniae on the structure of the surface carbohydrates of the chinchilla eustachian tube and middle ear mucosa.
    Linder TE; Daniels RL; Lim DJ; DeMaria TF
    Microb Pathog; 1994 Jun; 16(6):435-41. PubMed ID: 7830530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobacco smoke and otitis media in the chinchilla model.
    Antonelli PJ; Daly KA; Juhn SK; Veum EJ; Adams GL; Giebink GS
    Otolaryngol Head Neck Surg; 1994 Oct; 111(4):513-8. PubMed ID: 7936688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Otitis media: the chinchilla model.
    Giebink GS
    Microb Drug Resist; 1999; 5(1):57-72. PubMed ID: 10332723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical study of protease inhibitors in experimental otitis media with effusion.
    Juhn SK; Hamaguchi Y
    Ann Otol Rhinol Laryngol Suppl; 1988; 132():10-3. PubMed ID: 2454602
    [No Abstract]   [Full Text] [Related]  

  • 16. Uptake of horseradish peroxidase by the middle ear mucosa in experimentally induced otitis media.
    Sakagami M; Harada T; Juhn SK; Duvall AJ; Matsunaga T
    Eur Arch Otorhinolaryngol; 1990; 248(2):113-8. PubMed ID: 2282213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating amoxicillin influx/efflux in chinchilla middle ear fluid and simultaneous measurement of antibacterial effect.
    Huang Y; Yang Z; Cartier L; Cheung B; Sawchuk RJ
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4336-41. PubMed ID: 17923485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandins and otitis media: studies in the chinchilla.
    Jung TT; Smith DM; Juhn SK; Gerrard JM
    Otolaryngol Head Neck Surg (1979); 1980; 88(3):316-23. PubMed ID: 7402673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of pneumococcal cell wall to the pathogenesis of experimental otitis media.
    Ripley-Petzoldt ML; Giebink GS; Juhn SK; Aeppli D; Tomasz A; Tuomanen E
    J Infect Dis; 1988 Feb; 157(2):245-55. PubMed ID: 3335809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media.
    Hall-Stoodley L; Hu FZ; Gieseke A; Nistico L; Nguyen D; Hayes J; Forbes M; Greenberg DP; Dice B; Burrows A; Wackym PA; Stoodley P; Post JC; Ehrlich GD; Kerschner JE
    JAMA; 2006 Jul; 296(2):202-11. PubMed ID: 16835426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.